W. R. Berkley
Corporate profile
🏛️ Legal entity. W. R. Berkley Corporation is a Delaware-incorporated insurance holding company headquartered at 475 Steamboat Road, Greenwich, Connecticut (CIK 0000011544), founded in 1967 by William R. Berkley.[1] The company is among the largest commercial-lines writers in the United States and operates worldwide through a decentralized model of 60 specialized operating businesses, each focused on a niche industry, product, or territory. It is a Fortune 500 company (historically ranked 397th) and an S&P 500 component, listed on the NYSE under the ticker "WRB" — changed from "BER" on April 15, 2008 and originally listed as "BKLY" on Nasdaq from its 1973 IPO, then "BER" on the NYSE from May 9, 2001.
📊 Scale. WRB employs 8,804 people (including 8,678 at its insurance subsidiaries) across 60 (re)insurance businesses; third-party trackers cite a closely consistent ~8,727 worldwide at year-end 2025.[1] It reports in two segments: Insurance and Reinsurance & Monoline Excess. The accounting basis is US GAAP; solvency regimes are NAIC RBC for US subsidiaries and Solvency II / Lloyd's for UK and European entities.
🏢 Key regulated entities. Berkley Insurance Company (Wilmington, DE) is the lead pooled carrier; the rated group ("W. R. Berkley Insurance Group," or Berkley Group) includes Admiral Insurance, Nautilus Insurance, Berkley Regional, Berkley National, Berkley Specialty, Berkley Assurance, Berkley Casualty, Acadia Insurance, Continental Western, Key Risk Insurance, Midwest Employers Casualty, Carolina Casualty, Preferred Employers, StarNet, Gemini, Great Divide, Riverport, Union, and others, plus Berkley Life and Health (Urbandale, IA). International platforms include W. R. Berkley Syndicate 1967 at Lloyd's (managed by W/R/B Underwriting Limited, with a Lloyd's China underwriting division), W. R. Berkley Europe AG, Berkley Re Australia, Berkley Re Asia, and Mexican subsidiaries (Berkley International Seguros Mexico; Berkley International Compañía de Garantías Mexico).
👤 Leadership. W. Robert Berkley, Jr. serves as Chairman (since June 9, 2026), President and CEO (President & CEO since October 2015); Richard M. Baio is Executive Vice President and CFO. Founder William R. Berkley served as Executive Chairman from 2015 until his death on June 9, 2026, at age 80. On that date, WRB announced "with deep sadness the passing of its founder and Executive Chairman," and the board immediately appointed Rob Berkley as Chairman.
⚖️ Founder succession assessment. Near-term operational and cultural continuity risk is low because Rob Berkley has led the company operationally for over a decade and the decentralized model devolves underwriting authority to approximately 60 unit presidents. Bill Berkley's famously candid quarterly-call commentary on cycle discipline, social inflation, and reserving was a cultural touchstone — he described the company as "a large group of small niches" — and his absence removes a unique source of institutional discipline and external credibility. The principal longer-term governance questions are the durability of the entrepreneurial, cycle-disciplined culture without its architect, and the evolving balance of power among the family bloc (~17%), Mitsui Sumitomo (~15.7%, now with a board seat), and public shareholders. The elder Berkley ranked 239th on the 2025 Forbes 400 with a net worth of roughly $6.7 billion.
🇯🇵 Strategic ownership shift. In March 2025, Mitsui Sumitomo Insurance (a unit of Japan's MS&AD) agreed to acquire up to 15% of WRB via open-market and third-party purchases (no shares from the company or the family). By early 2026 it beneficially owned 58,780,450 shares (~15.7%, later ~15.8% as of April 27, 2026), and its executive Andrew Carrier was elected to the board on June 3, 2026. The Berkley family ("WR Berkley & Others LLC") holds 63,515,547 shares (~17.0–17.1%), and a Framework Agreement governs voting coordination between the two blocs.
🔒 Credit strength. AM Best affirmed Berkley Insurance Group at FSR A+ (Superior) / Long-Term ICR "aa-" (Superior), and the holding-company ICR at "a-" (Excellent), with the ICR outlook revised to positive on July 3, 2025; adjusted debt leverage was 19.1% at year-end 2024 (down from 22.3% in 2020). S&P affirmed the holding company at BBB+, positive outlook, on February 25, 2025; Moody's rates the holding company Baa1 senior (stable) and the insurance subsidiaries A1; Fitch affirmed "A" (stable) on September 30, 2024.
Segment overview
🛡️ Insurance segment. The Insurance segment (~89% of GWP; $13.47 billion GWP in 2025) writes commercial P&C and specialty lines predominantly in the US, with operations also in the UK, Continental Europe, South America, Canada, Mexico, Scandinavia, Asia and Australia.[1] Product families include other liability (general/excess/umbrella — the largest line at $4.50 billion NWP in 2025), short-tail lines ($2.58 billion), commercial auto ($1.65 billion), workers' compensation ($1.28 billion), and professional liability ($1.16 billion). The segment is heavily weighted to commercial customers and specialty/E&S niches (construction, energy/oil & gas, environmental, cyber, marine, healthcare, high-net-worth, professional liability), and distribution is via independent agents, retail and wholesale/surplus-lines brokers, and program administrators.
🔄 Reinsurance & Monoline Excess segment. The Reinsurance & Monoline Excess segment (~11% of GWP; $1.64 billion GWP in 2025) writes treaty and facultative casualty and property reinsurance plus monoline excess workers' compensation, operating in the US, UK, Continental Europe, Australia, Asia-Pacific and South Africa via Berkley Re and the Lloyd's syndicate. In 2025 the NWP split was casualty $740 million, property $485 million, and monoline excess $302 million.
🏆 Competitive position. WRB is a top-five US E&S underwriter (it was the fourth-largest domestic US E&S underwriter in 2024) and one of the largest US commercial-lines writers. Its differentiators are the decentralized "large group of small niches" model giving each unit small-business agility with large-balance-sheet backing; disciplined cycle management (willingness to shrink lines when pricing is inadequate); deep niche specialization; and an entrepreneurial, owner-operator culture. Goldman Sachs describes WRB as "the most concentrated casualty insurer" in its coverage basket.
Segment performance
📈 Insurance segment results. Insurance segment combined ratios ran 89.4% (2021), 89.2% (2022), ~89.2% (2023), 91.2% (2024) and 91.7% (2025).[1][2] The loss ratio rose from 61.1% (2021) to 63.5% (2025), while the expense ratio improved modestly from 28.3% to 28.2%. NWP grew from $7.74 billion (2021) to $11.18 billion (2025), and pre-tax income rose from $1.22 billion (2021) to $2.03 billion (2025).
🔁 Reinsurance segment results. Reinsurance & Monoline Excess combined ratios improved markedly: 90.7% (2021), 89.7% (2022), ~88% (2023), 84.1% (2024) and 83.7% (2025), reflecting favorable property settlements and excess workers'-comp performance. NWP grew from $1.12 billion (2021) to $1.53 billion (2025).
💲 Pricing signals. Average rate increases excluding workers' comp were approximately 7.5% (FY2021), ~8.0% (FY2023) and 7.6% (FY2025), but moderated to approximately 2.9% in Q4 2025 as the market stabilized, with headline ex-comp rate of ~7.1–7.2% in late 2025/Q1 2026 (the gap reflecting mix).[3] The current-accident-year combined ratio excluding catastrophes was consistently strong — 87.9% in Q4 2025 and 88.3% in Q1 2026. Catastrophe losses totaled $336.4 million in 2025 (versus $297.6 million in 2024).
⚠️ Concentration risk. Other liability (casualty) is the dominant and longest-tail line, making casualty reserve adequacy the single most material risk variable. Workers' comp and professional liability provide diversification and a reserve cushion.
Strategy priorities
🎯 Strategic pillars. WRB's strategic pillars are underwriting excellence, disciplined cycle management, and exceeding a 15% after-tax return on beginning-of-year equity "for the foreseeable future" — a target management has exceeded in every year FY2021–FY2025.[1][2] Growth is organic and niche-driven, centered on launching new operating units and expanding E&S, specialty, and international footprint (e.g., India GIFT City branch approval; European branch expansion including a new Swiss branch in 2024). M&A appetite is opportunistic and secondary to organic unit creation.
🖥️ Technology and efficiency. Transformation priorities center on technology/data analytics and AI investment (expected to peak in 2026, with benefits from 2027), claims, and operational efficiency, with a stated goal of keeping the expense ratio "comfortably below 30%." Post-founder strategy continuity is high given Rob Berkley's decade-long tenure and the institutionalized decentralized model.
Income statement
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Gross premiums written | 10,700,134 | 11,909,052 | ~12,995,632 | 14,211,090 | 15,105,069 |
| Net premiums written | 8,862,867 | 10,004,070 | ~10,954,467 | 11,972,096 | 12,711,327 |
| Net premiums earned | 8,106,031 | 9,561,429 | ~10,400,687 | 11,548,485 | 12,446,938 |
| Net investment income | 671,618 | 779,185 | ~1,053,000 | 1,333,161 | 1,429,067 |
| Net investment gains (losses) | 90,632 | 202,397 | — | 117,708 | 132,220 |
| Revenues from non-insurance businesses | 489,151 | 509,548 | — | 528,012 | 577,420 |
| Total revenues | 9,455,466 | 11,166,499 | ~12,140,000 | 13,638,752 | 14,707,856 |
| Pre-tax income | 1,282,905 | 1,719,681 | ~1,800,000 | 2,264,493 | 2,280,543 |
| Operating income (non-GAAP) | 951,861 | 1,223,934 | ~1,380,000 | 1,626,497 | 1,729,408 |
| Net income to common | 1,022,490 | 1,381,062 | 1,381,392 | 1,756,115 | 1,779,403 |
| EPS diluted (split-adjusted) | 3.66 | 4.94 | — | 4.36 | 4.45 |
| Combined ratio | 89.6% | 89.3% | ~90.2% | 90.3% | 90.7% |
| Loss ratio | 61.1% | 61.3% | ~62.0% | 61.8% | 62.4% |
| Expense ratio | 28.5% | 28.0% | ~28.2% | 28.5% | 28.3% |
| ROE (reported) | 16.2% | 20.8% | 23.6% | 23.6% | 21.2% |
| Operating ROE (non-GAAP) | 15.1% | 18.4% | 22.4% | 21.8% | 20.6% |
📋 Restatement and split adjustments. FY2024 figures were later restated to exclude after-tax FX from operating income (originally-reported FY2024 operating ROE of 22.4% restated to 21.8%).[4][3] Per-share figures reflect the 3-for-2 stock splits of March 2022 and July 2024.
📊 Peer ROE comparison. WRB's ROE of 23.6% (2023), 23.6% (2024) and 21.2% (2025) was consistently the highest and least volatile of its peer cohort. Markel Group averaged approximately 13% annual ROE (2025), lower and more volatile due to equity-portfolio mark-to-market and Markel Ventures. Everest Group produced a 10.5% net-income ROE (2025), down sharply from prior years due to US casualty reserve charges; 2024 was severely depressed by approximately $1.5 billion of unfavorable prior-year development. Hanover (THG) achieved approximately 20% (2025) and 16.1% (2024), driven by a strong personal-lines recovery.
Balance sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Total assets | 32,086,414 | 33,861,099 | ~37,000,000 | 40,567,268 | 44,071,071 |
| Net invested assets | 23,705,508 | 24,545,672 | ~27,000,000 | 29,780,638 | 33,173,381 |
| Total fixed maturity securities | — | 17,587,349 | — | 23,010,899 | 25,047,662 |
| Loss & LAE reserves (gross) | 15,390,888 | 17,011,223 | ~18,500,000 | 20,368,030 | 22,207,773 |
| Reinsurance recoverables on unpaid losses | — | — | — | 3,201,389 | 3,254,099 |
| Senior notes & other debt | 2,259,416 | 1,828,823 | ~1,830,000 | 1,831,158 | 1,829,198 |
| Subordinated debentures | 1,007,652 | 1,008,371 | ~1,009,000 | 1,009,808 | 1,010,527 |
| Common stockholders' equity | 6,653,011 | 6,748,332 | ~7,500,000 | 8,395,111 | 9,700,818 |
| Book value per share (split-adjusted) | 25.09 | 25.51 | — | 22.09 | 25.72 |
🏗️ Leverage. Debt-to-capital was approximately 22.3% in 2020, declining to ~19.1% adjusted at year-end 2024 per AM Best; management cited financial leverage of 22.6% on a broader basis at year-end 2025.[1] WRB's leverage is modest and trending down, with strong interest coverage. The optical decline in book value per share from $25.51 (2022) to $22.09 (2024) reflects the July 2024 3-for-2 stock split, not value destruction — total stockholders' equity rose throughout.
Claims reserving
📐 Reserving philosophy. WRB sets reserves at management's best estimate based on "an actuarially derived point estimate and other considerations," using paid- and incurred-loss development, Bornhuetter-Ferguson, and frequency/severity methods, plus qualitative considerations (re-underwriting initiatives, mix, distribution, terms).[1] KPMG (auditor since 1972) treats loss reserves as a Critical Audit Matter and, using its own actuarial specialists, develops an independent range of reserves based on actuarial methodologies and assumptions. Gross reserves were $22.21 billion at year-end 2025 (up from $20.37 billion); reinsurance recoverables on unpaid losses (ceded reserves) were $3.25 billion; approximately $1.4 billion of workers'-comp reserves are discounted (aggregate net discount ~$420 million, weighted-average rate 3.6%).
| Fiscal year | Consolidated | Insurance | Reins. & Monoline Excess |
|---|---|---|---|
| FY2021 | +7 favorable | +20 favorable | (13) adverse |
| FY2022 | (36) adverse | (40) adverse | +4 favorable |
| FY2023 | (19) adverse | (24) adverse | +5 favorable |
| FY2024 | +4 favorable | (8) adverse | +12 favorable |
| FY2025 | +3 favorable | (44) adverse | +47 favorable |
🔎 Development drivers. Adverse Insurance-segment development has been concentrated in commercial auto liability (accident years ~2019–2023) and other liability — umbrella/excess (accident years ~2017–2022), with management noting "a significant component stemming from underlying auto exposures." FY2022 also reflected COVID-19 losses (event cancellation/film production). Favorable development came from workers' compensation (accident years 2020–2024), professional liability (accident years 2022–2023), and short-tail/property lines. The Reinsurance segment turned net favorable from 2022 onward, led by property (2024 accident year) and excess workers' comp.
📣 Social inflation commentary. Rob Berkley has repeatedly flagged social inflation, especially in auto-related liability and umbrella/excess, even while booking modest favorable consolidated development.[3] On the Q4 2024 call he characterized much of the liability market as "plagued by social inflation," citing an emboldened plaintiffs' bar and litigation funding, and pinpointed commercial auto liability and medical malpractice as most exposed. The cushion is thinning: Evercore ISI noted WRB had less favorable prior-year development on comp in 2025 and warned that workers' comp will probably provide less favorable development that can be used to offset continued strengthening in other liability. Conversely, Goldman Sachs's bull case argues that litigation reform and decelerating casualty claims inflation could turn development favorable, and upgraded WRB to Buy partly on that thesis.
🌀 Catastrophe exposure. WRB is primarily a casualty/specialty writer with relatively modest cat exposure; 2025 cat losses of $336.4 million (~2.7 points) included Q1 California wildfires and 2024 ($297.6 million) included Hurricane Milton. Key perils are US wind, severe convective storms, and international property via the reinsurance book.
🏁 Peer reserve comparison. WRB's development track record is vastly superior to Everest's. Everest reported approximately $1.5 billion of net unfavorable prior-year development plus ~$229 million of increased current-accident-year losses — totaling roughly $1.7 billion — concentrated in US casualty, which drove a Q4 2024 group combined ratio of 135.5% (Insurance segment 239.2%); it then booked a further ~$478 million of net adverse development in Q3 2025 (+12.4 points to the group combined ratio) and entered a $1.2 billion adverse-development cover (effective October 1, 2025, via Longtail Re, a Stone Ridge affiliate) over $5.4 billion of North American 2024-and-prior liability reserves, while selling ~$2 billion of retail commercial renewal rights to AIG. Markel ran $484.0 million of favorable development in 2025 (versus $454.9 million in 2024) but placed its Global Reinsurance division into run-off. Hanover ran modest favorable development. WRB's near-zero net consolidated development masks an internal pattern of casualty strengthening offset by comp/property releases — a more transparent and conservative posture than Everest's, but one warranting continued scrutiny as the comp cushion narrows.
Reinsurance
🔗 Objectives and structure. WRB purchases outward reinsurance for earnings protection, catastrophe protection, and capital relief, at both the group level and the individual operating-unit level (across 58+ units).[1] This dual structure affects ceding commissions and quota-share economics and contributes to quarter-to-quarter loss-ratio mix swings (management explicitly attributes part of attritional-loss-ratio movement to unit-level reinsurance buying). Ceded reserves were $3.25 billion at year-end 2025 against $22.21 billion gross reserves, implying high net retention (roughly 85%); ceded earned premiums were ~$2.34 billion in 2025. Short-tail and property lines carry the bulk of catastrophe cessions; long-tail casualty is largely retained net — consistent with a casualty-concentrated writer confident in its own reserving.
📥 Own assumed reinsurance. The Reinsurance & Monoline Excess segment ($1.64 billion GWP, 83.7% combined ratio in 2025) is a disciplined, diversified assumed-reinsurance book (casualty, property, monoline excess WC) written globally via Berkley Re and Lloyd's. It both supports the group's return profile and serves external cedants; it is run with the same cycle discipline as the primary book and has been a strong recent performer, though management has flagged property reinsurance as a line where pricing momentum has clearly reversed.
✅ Counterparty quality. Reinsurance recoverables are modest relative to capital and reserves; the allowance for expected credit losses on amounts due from reinsurers was small (~$7 million), indicating high counterparty quality.
Solvency
💎 Capital adequacy. AM Best assesses Berkley Group's balance-sheet strength at the "strongest" level, anchored by risk-adjusted capitalization "consistently being at the strongest level" as measured by Best's Capital Adequacy Ratio (BCAR).[1] The group has grown GAAP surplus organically over the most recent 10-year period and improved financial leverage. Enterprise risk management is assessed as "appropriate," supported by stochastic modeling and stress testing.
| Agency | Operating subsidiaries | Holding company | Latest action |
|---|---|---|---|
| AM Best | FSR A+ (Superior), stable; Long-Term ICR "aa-" (Superior), positive | ICR "a-" (Excellent), positive | Affirmed July 3, 2025; ICR outlook revised to positive |
| S&P Global | A+ (Strong) | BBB+, positive | Affirmed February 25, 2025 |
| Moody's | A1 (insurance subsidiaries) | Baa1 senior, stable | Affirmed April 2024 |
| Fitch | — | A, stable | Affirmed September 30, 2024 |
📑 Debt ratings and leverage. Adjusted debt leverage was 19.1% at year-end 2024 per AM Best (down from 22.3% in 2020); interest coverage and liquidity are strong. AM Best rates the senior notes "a-" (Excellent) and the subordinated debentures "bbb+" (Good).
🏦 Regulatory constraints. Dividends from US insurance subsidiaries to the holding company are subject to state insurance-law limits (typically the greater of 10% of surplus or prior-year net income, with prior-approval thresholds for amounts above that). The holding company maintains substantial liquidity (cash and equivalents near $2 billion at points in 2024–2025) plus access to credit facilities and the capital markets. UK and European entities are governed by Solvency II and Lloyd's capital requirements; AM Best noted rising data and reporting expectations at Lloyd's and in the UK as an industry-wide operational consideration.
Capital allocation
💰 Dividends. WRB pays a modest regular quarterly dividend (raised 12.5% in June 2025 to $0.09/quarter; raised 11.1% in 2026, marking the 25th consecutive annual increase, putting it on track to become a Dividend Aristocrat in 2027) supplemented by frequent, larger special dividends.[1] In 2025 it paid special dividends of $0.50 (June) and $1.00 (December), totaling $1.50/share — the largest special dividends in its history. Total capital returned in 2025 was $970.5 million ($567.6 million special dividends, $270.2 million buybacks, $132.7 million regular dividends). The company has maintained dividend payments for over 50 consecutive years.
🔄 Buybacks. WRB repurchased 4,069,026 shares for $270.2 million in 2025 (including ~2.9 million shares for $196.4 million in Q4), and ~4.47 million shares for $302 million in Q1 2026. It increased its repurchase authorization in January 2026. Buybacks are opportunistic and price-sensitive.
🎯 Capital priorities. Stated priority order: organic growth and new-unit launches first; then debt management; then return of excess capital via buybacks and special dividends "as strong earnings rapidly generate additional excess capital." The 15% after-tax ROE target governs deployment.
📊 Peer payout comparison. WRB's special-dividend-led approach resembles American Financial Group's. Markel pays no dividend and relies on buybacks ($344 million through Q3 2025) and Ventures reinvestment. Everest pays a regular dividend and resumed ~$397 million of buybacks in Q4 2025 after wind season. Hanover pays a growing regular dividend ($3.80 annualized, +5.6%) plus modest buybacks ($130.1 million in 2025). WRB's total payout flexibility is high given low leverage and strong cash flow.
Investigation findings
🔍 Founder succession and key-person risk. Near-term operational risk is low because Rob Berkley has served as CEO since 2015 and the decentralized model devolves authority to approximately 60 unit heads. Moderate long-term cultural and governance risk persists, stemming from the loss of founder authority and a newly three-way ownership structure among the family, Mitsui Sumitomo, and public holders.
⚖️ Social inflation and casualty reserve adequacy. Modest net adverse Insurance-segment development (commercial auto, umbrella) has been offset by comp/property releases; WRB is far more conservative than Everest. The narrowing workers'-comp release cushion is the key forward risk.
📐 Decentralized model scalability. As GWP scaled past $15 billion, the expense ratio actually improved (to 28.3%) and combined ratios held in the low 90s — there is little evidence of scalability strain. The main control challenge is consistent casualty reserving across 60 units, monitored via group ERM and KPMG's independent reserve range.
📉 E&S cycle positioning. AM Best revised the US E&S outlook to stable from positive on November 18, 2025, citing rate softening and slowing premium growth; WRB's headline rate ex-comp moderated to ~2.9% in Q4 2025. Management is reducing exposure where pricing is inadequate (notably property reinsurance and some professional lines) while still finding pockets of opportunity, and the agency still expects E&S writers to outperform the broader P&C industry in 2026.
💵 Investment and non-insurance income. Net investment income ($1.43 billion in 2025) is the larger and more stable earnings engine. Investment-fund and arbitrage income add volatility (investment funds swung from +$220 million in 2021 to –$11.5 million in 2024 to +$27.6 million in 2025); non-insurance businesses contributed $577 million of revenue against $552 million of expense in 2025 (thin margin). Equity-portfolio mark-to-market drives net-investment-gain volatility but is excluded from operating income — appropriately, given its noise.
Recommendations
🏦 Fixed-income investors. WRB is a high-quality holding with improving leverage (19.1% adjusted), strongest-level BCAR, and a positive AM Best ICR outlook. Senior notes ("a-"/BBB+/Baa1) warrant treatment as core holdings. An upgrade trigger would be an AM Best ICR upgrade to "a" (the positive outlook signals this is plausible within 12–24 months) or S&P moving the holding company to A-. A reduce trigger would be net adverse reserve development exceeding ~3% of reserves in any year (a Moody's-cited downgrade threshold), or debt-to-capital rising back above ~25%.
📈 Equity investors. WRB warrants a quality premium for best-in-class, low-volatility returns, but the stock traded near 3.0x book value in 2025 — a level several analysts flagged as full, prompting UBS, BofA Securities, Mizuho and Cantor Fitzgerald to move to Neutral/Hold in 2025. Core positions should be held, with accumulation on pullbacks toward ~2.3–2.5x book. Stage 2 catalysts to add include evidence that Insurance-segment casualty reserve strengthening is plateauing, litigation-reform tailwinds materializing (the Goldman bull case), or accretive payoff from the 2026 AI/technology investments beginning in 2027. Thesis-changing benchmarks are two-plus consecutive quarters of accelerating Insurance-segment adverse development, workers'-comp releases turning unfavorable, or a combined ratio sustained above ~93%.
👁️ Governance monitoring. The Mitsui Sumitomo relationship is now structural — Andrew Carrier joined the board on June 3, 2026, and MSI holds ~15.7–15.8%. Watch for any amendments to the Framework Agreement or family LLC voting arrangements, any MSI move beyond 15%, or any erosion of the family's voting bloc, each of which would materially change the control calculus following the founder's death.
Caveats
📝 Data precision. Several FY2023 income-statement and balance-sheet line items are approximate (marked "~") because exact figures were not captured verbatim from the FY2023 Form 10-K; users requiring audited precision should confirm against that filing. FY2021, FY2022, FY2024 and FY2025 figures are sourced directly from earnings releases and 10-K data.
🔢 Split adjustments. WRB's per-share, book-value and ROE figures reflect two stock splits (3-for-2 in March 2022 and July 2024); historical per-share comparisons must be split-adjusted. The optical decline in book value per share from $25.51 (2022) to $22.09 (2024) reflects the July 2024 split, not value destruction.
📊 Non-GAAP measures. "Operating income" and "operating ROE" are non-GAAP; the 2024 definition was restated in 2025 to exclude after-tax FX, so cross-year comparisons should use the restated basis. Segment prior-year development figures are management's MD&A "net of additional/return premiums" amounts and reconcile approximately, not exactly, to the consolidated net development figure.
⚠️ Peer comparability. Peer figures use each company's reported segment definitions, which differ materially (Markel includes Ventures/Financial/Consumer and an Insurance combined ratio rather than a group ratio; Everest is reinsurance-weighted at ~70% of GWP and recast its segments in 2025; Hanover includes personal lines). Direct combined-ratio/ROE comparisons should account for these mix differences. Everest's ~$1.7 billion reserve total reflects ~$1.5 billion of prior-year unfavorable development plus ~$229 million of increased current-accident-year losses recognized around Q4 2024/early 2025; its $1.2 billion adverse-development cover was announced October 27, 2025 (effective October 1, 2025).
🔮 Forward-looking statements. Management statements (the 15% ROE target, expense ratio "comfortably below 30%," 2027 technology benefits) are aspirations, not guarantees, and are subject to the cyclical, long-tail risks disclosed in WRB's filings. NAIC RBC ratios for the Berkley Insurance Company pool are not disclosed in SEC filings; AM Best's BCAR (assessed at the "strongest" level) is used as the external capital-adequacy proxy.
W. R. Berkley Corporation | |
|---|---|
| W. R. Berkley Corporation | |
| Corporate identity | |
| Type | Insurance holding company (publicly traded) |
| Traded as | NYSE WRB |
| Founded | 1967 |
| Headquarters | 475 Steamboat Road, Greenwich, Connecticut |
| Domicile | Delaware |
| Major shareholders | Berkley family (~17.0%); Mitsui Sumitomo Insurance (~15.7–15.8%); public float |
| Key people | W. Robert Berkley, Jr. (Chairman, President & CEO); Richard M. Baio (EVP & CFO) |
| Number of employees | 8,804 |
| Business & markets | |
| Lines of business | Commercial P&C, specialty/E&S, workers' compensation, professional liability, reinsurance |
| Distribution | Independent agents, retail and wholesale/surplus-lines brokers, program administrators |
| Key financials (December 31) | |
| Market cap | ~$25 billion |
| Gross written premium | $15.11 billion (FY2025) |
| Net income | $1.78 billion (FY2025) |
| Invested assets | $33.17 billion (FY2025) |
| Technical reserves | $22.21 billion gross (FY2025) |
| Equity | $9.70 billion (FY2025) |
| Combined ratio | 90.7% (FY2025) |
| Return on equity | 21.2% (FY2025) |
| External ratings | AM Best A+ (Superior) FSR; S&P A+ (operating); Moody's A1; Fitch A (holding co.) |
🏛️ W. R. Berkley Corporation is a Delaware-incorporated insurance holding company founded in 1967 by William R. Berkley, headquartered at 475 Steamboat Road, Greenwich, Connecticut, and listed on the NYSE under "WRB." The company operates through a decentralized model of 60 specialized (re)insurance businesses, each focused on a niche industry, product, or territory, employing approximately 8,800 people and reporting in two segments — Insurance and Reinsurance & Monoline Excess — under US GAAP (with NAIC RBC for US subsidiaries and Solvency II / Lloyd's for UK and European entities). It is a Fortune 500 company and S&P 500 component with a market value of roughly $25 billion.
🛡️ Segment structure. The Insurance segment (~89% of GWP; $13.47 billion GWP in FY2025) writes commercial P&C and specialty lines predominantly in the US, spanning other liability ($4.50 billion NWP), short-tail lines ($2.58 billion), commercial auto ($1.65 billion), workers' compensation ($1.28 billion) and professional liability ($1.16 billion). The Reinsurance & Monoline Excess segment (~11% of GWP; $1.64 billion GWP) writes treaty and facultative casualty and property reinsurance plus monoline excess workers' compensation via Berkley Re and Lloyd's Syndicate 1967. WRB is a top-five US E&S underwriter and one of the largest US commercial-lines writers, differentiated by its decentralized "large group of small niches" model, disciplined cycle management, deep niche specialization, and entrepreneurial culture.
📈 Segment performance. Insurance segment combined ratios ran 89.4% (2021), 89.2% (2022), ~89.2% (2023), 91.2% (2024) and 91.7% (2025), with the loss ratio rising from 61.1% to 63.5% and the expense ratio improving modestly from 28.3% to 28.2%. The Reinsurance & Monoline Excess segment improved markedly from a 90.7% combined ratio (2021) to 83.7% (2025). Average rate increases excluding workers' comp were approximately 7.5% (FY2021) and 7.6% (FY2025), but moderated to ~2.9% in Q4 2025 as the market stabilized, while catastrophe losses totaled $336.4 million in 2025 (~2.7 points).
🎯 Strategy and growth. WRB's strategic pillars are underwriting excellence, disciplined cycle management, and exceeding a 15% after-tax return on beginning-of-year equity — a target exceeded in every year FY2021–FY2025. Growth is organic and niche-driven, centered on launching new operating units and expanding E&S, specialty and international footprint, with AI and technology investment expected to peak in 2026 and deliver benefits from 2027.
💰 Profitability and income. Gross written premiums grew from $10.70 billion (2021) to a record $15.11 billion (2025); net investment income rose from $672 million to $1.43 billion as the company reinvested record operating cash flow ($3.58 billion in 2025) at new-money yields above book yield on a short-duration, AA–rated fixed-maturity portfolio. Reported ROE was 16.2% (2021), 20.8% (2022), 23.6% (2023), 23.6% (2024) and 21.2% (2025) — consistently the highest and least volatile of the peer cohort (Markel ~13%, Everest 10.5%, Hanover ~20% in FY2025).
🏗️ Balance sheet strength. Total assets grew from $32.1 billion (2021) to $44.1 billion (2025), with common stockholders' equity rising from $6.65 billion to $9.70 billion and book value per share reaching $25.72 (split-adjusted). Debt-to-capital declined to ~19.1% adjusted at year-end 2024 per AM Best, and management cited financial leverage of 22.6% on a broader basis at year-end 2025; gross loss and LAE reserves reached $22.21 billion against $3.25 billion of ceded reserves, implying high net retention of roughly 85%.
🔎 Claims reserving and social inflation. The Insurance segment booked modest net adverse prior-year development in 2022–2025, concentrated in commercial auto liability ( accident years ~2019–2023) and umbrella/excess (accident years ~2017–2022), offset by favorable workers'-comp and short-tail releases. Rob Berkley has repeatedly flagged social inflation and litigation funding as casualty headwinds, and the workers'-comp release cushion is narrowing — Evercore ISI warned that comp will probably provide less favorable development to offset continued other-liability strengthening. WRB's development track record is vastly superior to Everest's, which took roughly $1.7 billion of casualty charges and entered a $1.2 billion adverse-development cover in 2025.
🔒 Reinsurance and solvency. WRB purchases outward reinsurance for earnings protection, catastrophe protection and capital relief at both the group and operating-unit level, with high net retention (~85%) and long-tail casualty largely retained net. AM Best assesses balance-sheet strength at the "strongest" level with BCAR consistently at the strongest level; FSR is A+ (Superior), and the holding-company ICR outlook was revised to positive on July 3, 2025 with adjusted debt leverage at 19.1%.
👤 Capital allocation and governance. WRB returned $970.5 million to shareholders in 2025 ($567.6 million special dividends, $270.2 million buybacks, $132.7 million regular dividends) and has maintained dividend payments for over 50 consecutive years, with the 25th consecutive annual increase in 2026 putting it on track for Dividend Aristocrat status in 2027. The June 9, 2026 death of founder William R. Berkley at age 80 and immediate elevation of son Rob Berkley to Chairman represents low near-term execution risk but removes irreplaceable founder-anchored cultural authority. The evolving three-way ownership structure — the Berkley family (~17%), Mitsui Sumitomo Insurance (~15.7%, with board seat from June 2026 via Andrew Carrier), and public holders — governed by a Framework Agreement, is the key long-term governance variable to monitor.
The following sections provide further details.
References
- ↑ 1.00 1.01 1.02 1.03 1.04 1.05 1.06 1.07 1.08 1.09 "W. R. Berkley Corporation FY2025 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. 2026. Retrieved June 26, 2026.
- ↑ 2.0 2.1 "W. R. Berkley Corporation FY2024 Annual Report (Form 10-K)". U.S. Securities and Exchange Commission. 2025. Retrieved June 26, 2026.
- ↑ 3.0 3.1 3.2 "W. R. Berkley (WRB) Q4 2025 Earnings Call Transcript". The Motley Fool. January 27, 2026. Retrieved June 26, 2026.
- ↑ "W. R. Berkley Corporation FY2025 Annual Report Supplement" (PDF). U.S. Securities and Exchange Commission. 2026. Retrieved June 26, 2026.
Sources
This article draws on the following sources as catalogued in the original due-diligence document:
Regulatory filings
- SEC EDGAR, FY2025 10-K (wrb-20251231.htm) — Annual report for the fiscal year ended December 31, 2025.
- SEC EDGAR, FY2024 10-K (wrb-20241231.htm) — Annual report for the fiscal year ended December 31, 2024.
- SEC EDGAR, FY2025 Annual Report Supplement (d769283dars.pdf) — Annual report supplement filed 2026.
Company materials
- Earnings call transcripts (Motley Fool) — Q4 2025 earnings call transcript, January 27, 2026.
Rating agencies
- AM Best — FSR A+ (Superior) affirmation, July 3, 2025; ICR outlook revised to positive.
- S&P Global — BBB+ holding-company affirmation, positive outlook, February 25, 2025.
- Moody's — Baa1 senior holding-company rating, stable, affirmed April 2024.
- Fitch Ratings — "A" holding-company affirmation, stable, September 30, 2024.
Industry and peer sources
- Goldman Sachs, UBS, BofA Securities, Mizuho, Cantor Fitzgerald, Evercore ISI — Sell-side equity research coverage and rating actions cited in the due-diligence document.
- AM Best E&S Market Review — US E&S outlook revision to stable, November 18, 2025.
- Forbes 400 (2025) — William R. Berkley net worth ranking.